» Articles » PMID: 38544366

Serum Heme Oxygenase-1 Level Predicts Clinical Outcome After Acute Ischemic Stroke

Overview
Specialties Neurology
Pharmacology
Date 2024 Mar 28
PMID 38544366
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The relationship between heme oxygenase-1 (HO-1) and human ischemic stroke outcome remains unclear, which was investigated in this study.

Methods: Acute ischemic stroke patients admitted within 24 h were enrolled. Serum HO-1 levels at baseline were measured via ELISA. Poor 3-month functional outcome was defined as modified Rankin Scale (mRS) score 3-6. Multivariable-adjusted binary logistic regression and restricted cubic spline models were employed to examine association between serum HO-1 and functional outcome. HO-1's additive prognostic utility was assessed by net reclassification index (NRI) and integrated discrimination improvement (IDI).

Results: Of 194 eligible patients, 79 (40.7%) developed poor functional outcomes at 3-month follow-up. The highest quartile of serum HO-1 was independently associated with a lower risk of poor functional outcome (adjusted OR 0.13, 95% CI 0.04-0.45; p = 0.001) compared with the lowest HO-1 category. The relationship between higher HO-1 levels and reduced risk of poor functional outcome was linear and dose responsive (p = 0.002 for linearity). Incorporating HO-1 into the analysis with conventional factors significantly improved reclassification for poor functional outcomes (NRI = 41.2%, p = 0.004; IDI = 5.0%, p = 0.004).

Conclusions: Elevated serum HO-1 levels at baseline were independently associated with improved 3-month functional outcomes post-ischemic stroke. Serum HO-1 measurement may enhance outcome prediction beyond conventional clinical factors.

Citing Articles

Association between serum levels of insulin-like growth factor-binding proteins at admission and outcomes at 3 months after acute ischemic stroke.

Zhu Y, Wang H, Cui T, Chen M, Chen Y, Wu S Ann Med. 2025; 57(1):2472867.

PMID: 40048365 PMC: 11892070. DOI: 10.1080/07853890.2025.2472867.


Serum heme oxygenase-1 level predicts clinical outcome after acute ischemic stroke.

Wang H, Cui T, Chen Y, Chen M, Zhang S, Leng X CNS Neurosci Ther. 2024; 30(3):e14701.

PMID: 38544366 PMC: 10973699. DOI: 10.1111/cns.14701.

References
1.
Lin S, Wu B, Hao Z, Kong F, Tao W, Wang D . Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a Chinese hospital-based stroke study. Cerebrovasc Dis. 2011; 31(5):419-26. DOI: 10.1159/000323221. View

2.
Pencina M, DAgostino Sr R, DAgostino Jr R, Vasan R . Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2007; 27(2):157-72. DOI: 10.1002/sim.2929. View

3.
Wang K, Tang S, Lee J, Lai D, Huang S, Hsieh S . Prognostic value of intrathecal heme oxygenase-1 concentration in patients with Fisher Grade III aneurysmal subarachnoid hemorrhage. J Neurosurg. 2014; 121(6):1388-93. DOI: 10.3171/2014.7.JNS131704. View

4.
Jung K, Kwak M . The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010; 15(10):7266-91. PMC: 6259123. DOI: 10.3390/molecules15107266. View

5.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View